T Kishaba - Respiratory Investigation, 2022 - Elsevier
Interstitial lung disease (ILD) is a parenchymal lung disease and restrictive disorder that presents as diffuse infiltrative shadows. The initial diagnosis of ILD is important because …
JMJ Lemmers, MC Vonk… - European Respiratory …, 2022 - Eur Respiratory Soc
Objective: This COnsensus-based Standards for the selection of health measurement INstruments (COSMIN)-based systematic review aims to identify and summarise the quality …
Background Cough remains a persistent symptom in patients with idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs). To inform future research, treatment …
J Guiot, MS Njock - Frontiers in Medicine, 2023 - frontiersin.org
Pulmonary fibrosis is a debilitating and potentially progressive lung disease characterized by the excessive accumulation of fibrotic tissue within the lung parenchyma, leading to …
E Basaran, D Temiz Karadag, O Cakir, N Gokcen… - Clinical …, 2024 - Springer
Introduction/objectives Controversy exists regarding the concordance of patient-reported outcome measures (PROMs) with other assessment parameters in systemic sclerosis …
S Kundu, S Chatterjee, RK Haldar… - The Journal of …, 2024 - journals.lww.com
Background: Connective tissue diseases (CTDs) are one of the most common causes among the known etiologies of interstitial lung disorders (ILDs). Parenchymal involvement in …
Connective tissue disease-related interstitial lung disease (CTD-ILD) results in an unrelenting symptom burden and may progress to death. The morbidity and mortality …
S6 :Supplementary Table Risk of bias assessment of methods, reported results, individual and overall ratings and GRADE level of Page 1 S6 :Supplementary Table Risk of bias assessment …